[1] Wilson JW, Morales A, Bruce AW, et al. Interstitial radiotherapy for localized carcinoma of the prosptate[J]. Can J Surg, 1983, 26(4):363-365.
[2] Whitmore WF, Hilaris B, Grabstald H, et al. Retropublic implantation of iodine 125 in the treatment of prostatic cancer[J]. J Urol, 1972,108:918-920.
[3] Kumar PP, Bartone FF. Transperineal percutaneous I-125 implant of prostate[J]. Urology, 1981, 17(3):238-240.
[4] Elkin D, Kim JA, Constable WC. Anatomic localization of radioactive gold seeds of the prostate by compute-aided tomography[J]. Comput Tomogr, 1981, 5(1):89-93.
[5] Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinical localized, low to high gealson grade prostate carcinoma[J]. Cancer, 1998, 83(5):989-1001.
[6] Ragde H, Blasko JC, Grimm PD, et al. Brathytherapy for clinically localized prostate cancer:result at 7-and 8-year follow-up[J]. Semin Surg Oncol, 1997, 13(6):438-443.
[7] Battermann JJ, Boon TA, de Voogt HJ. Preliminary result with iodine-125 seed for permanent implantation in patients with localized prostate cancer[J]. Radiother Oncol, 1987, 10(2):91-95.